Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
==============================================================================================================================================================

* Hua Zhong
* Xueyan Zhang
* Panwen Tian
* Tianqing Chu
* Qisen Guo
* Xinmin Yu
* Zhuang Yu
* Yalun Li
* Lijuan Chen
* Jie Liu
* Yan Zhang
* Yan Guan
* Xun Shi
* Jing Wang
* Yanqiu Zhao
* Baohui Han